Wockhardt Launches Generic Wellbutrin SR

Share this article:

Wockhardt announced that it has received final FDA approval for marketing 100mg, 150mg and 200mg 12-Hr Extended Release Bupropion HCl Tablets, the generic version of GlaxoSmithKline's Wellbutrin SR, indicated for the treatment of depression.

Wockhardt is launching the product immediately.

For more information call (800) 346-6854 or visit www.wockhardtusa.com.

Share this article:

Related Resources

close

Next Article in Generics News